US30161N1019 - Common Stock - After market: 40.9 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-01-23 | Credit Suisse | Maintains | Outperform |
2022-12-15 | Morgan Stanley | Maintains | Overweight |
2022-11-11 | Morgan Stanley | Maintains | Overweight |
2022-11-04 | Mizuho | Maintains | Buy |
2022-10-21 | Morgan Stanley | Maintains | Overweight |
2022-10-20 | Keybanc | Downgrade | Overweight -> Sector Weight |
2022-10-19 | Wells Fargo | Maintains | Equal-Weight |
2022-10-19 | Credit Suisse | Initiate | Outperform |
2022-10-03 | Credit Suisse | Initiate | Outperform |
2022-09-22 | Morgan Stanley | Maintains | Overweight |
2022-08-31 | Mizuho | Maintains | Buy |
2022-08-23 | Morgan Stanley | Maintains | Overweight |
2022-08-04 | BMO Capital | Maintains | Outperform |
2022-08-04 | Wells Fargo | Maintains | Equal-Weight |
2022-07-21 | Morgan Stanley | Maintains | Overweight |
2022-07-19 | Keybanc | Maintains | Overweight |
2022-07-18 | Barclays | Maintains | Equal-Weight |
2022-06-30 | UBS | Maintains | Buy |
2022-06-08 | Argus Research | Maintains | Buy |
2022-05-23 | Morgan Stanley | Maintains | Overweight |
2022-05-10 | Wells Fargo | Maintains | Equal-Weight |
2022-04-27 | Wells Fargo | Maintains | Equal-Weight |
2022-04-20 | Keybanc | Maintains | Overweight |
2022-04-20 | JP Morgan | Upgrade | Neutral -> Overweight |
2022-04-20 | Morgan Stanley | Maintains | Overweight |
2022-04-07 | Keybanc | Maintains | Overweight |
2022-03-11 | Mizuho | Upgrade | Neutral -> Buy |
2022-02-07 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
2022-02-04 | Goldman Sachs | Downgrade | Buy -> Neutral |
2022-02-03 | Vertical Research | Downgrade | Buy -> Hold |
Find the competitors with the best analyst ratings on the USA